A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.

Autor: Smith, Keisha1 (AUTHOR), Pace, Amy2 (AUTHOR), Ortiz, Stephan3 (AUTHOR), Kazani, Shamsah4 (AUTHOR), Rottinghaus, Scott4 (AUTHOR) Scott.Rottinghaus@alexion.com
Zdroj: Trials. 7/13/2020, Vol. 21 Issue 1, p1-4. 4p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje